220 related articles for article (PubMed ID: 29907328)
1. Proapoptotic Cyclic Peptide BC71 Targets Cell-Surface GRP78 and Functions as an Anticancer Therapeutic in Mice.
Kao C; Chandna R; Ghode A; Dsouza C; Chen M; Larsson A; Lim SH; Wang M; Cao Z; Zhu Y; Anand GS; Ge R
EBioMedicine; 2018 Jul; 33():22-32. PubMed ID: 29907328
[TBL] [Abstract][Full Text] [Related]
2. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction.
Chen M; Zhang Y; Yu VC; Chong YS; Yoshioka T; Ge R
Cell Death Differ; 2014 May; 21(5):797-810. PubMed ID: 24464222
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.
Miao YR; Eckhardt BL; Cao Y; Pasqualini R; Argani P; Arap W; Ramsay RG; Anderson RL
Clin Cancer Res; 2013 Apr; 19(8):2107-16. PubMed ID: 23470966
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
[TBL] [Abstract][Full Text] [Related]
5. A therapeutically relevant, 3,3'-diindolylmethane derivative NGD16 attenuates angiogenesis by targeting glucose regulated protein, 78kDa (GRP78).
Nayak D; Amin H; Rah B; Ur Rasool R; Sharma D; Gupta AP; Kushwaha M; Mukherjee D; Goswami A
Chem Biol Interact; 2015 May; 232():58-67. PubMed ID: 25794856
[TBL] [Abstract][Full Text] [Related]
6. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
Qiao Y; Dsouza C; Matthews AA; Jin Y; He W; Bao J; Jiang F; Chandna R; Ge R; Fu L
Eur J Med Chem; 2020 May; 193():112228. PubMed ID: 32199134
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).
Zhou H; Zhang Y; Fu Y; Chan L; Lee AS
J Biol Chem; 2011 Jul; 286(29):25687-96. PubMed ID: 21622563
[TBL] [Abstract][Full Text] [Related]
9. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
10. Isthmin is a novel vascular permeability inducer that functions through cell-surface GRP78-mediated Src activation.
Venugopal S; Chen M; Liao W; Er SY; Wong WS; Ge R
Cardiovasc Res; 2015 Jul; 107(1):131-42. PubMed ID: 25952901
[TBL] [Abstract][Full Text] [Related]
11. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
Tseng CC; Zhang P; Lee AS
Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
[TBL] [Abstract][Full Text] [Related]
12. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice.
Xiang W; Ke Z; Zhang Y; Cheng GH; Irwan ID; Sulochana KN; Potturi P; Wang Z; Yang H; Wang J; Zhuo L; Kini RM; Ge R
J Cell Mol Med; 2011 Feb; 15(2):359-74. PubMed ID: 19874420
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.
Han KS; Li N; Raven PA; Fazli L; Frees S; Ettinger S; Park KC; Hong SJ; Gleave ME; So AI
Oncotarget; 2015 Oct; 6(33):34818-30. PubMed ID: 26472187
[TBL] [Abstract][Full Text] [Related]
14. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis.
Misra UK; Mowery Y; Kaczowka S; Pizzo SV
Mol Cancer Ther; 2009 May; 8(5):1350-62. PubMed ID: 19417154
[TBL] [Abstract][Full Text] [Related]
15. GRP78 signaling hub a receptor for targeted tumor therapy.
Sato M; Yao VJ; Arap W; Pasqualini R
Adv Genet; 2010; 69():97-114. PubMed ID: 20807604
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
17. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
Clarke WR; Amundadottir L; James MA
Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
[TBL] [Abstract][Full Text] [Related]
18. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway.
Xie J; Tao ZH; Zhao J; Li T; Wu ZH; Zhang JF; Zhang J; Hu XC
Biochem Biophys Res Commun; 2016 Jun; 474(3):612-619. PubMed ID: 27012209
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.
Kapoor V; Dadey DY; Nguyen K; Wildman SA; Hoye K; Khudanyan A; Bandara N; Rogers BE; Thotala D; Hallahan DE
J Nucl Med; 2016 Dec; 57(12):1991-1997. PubMed ID: 27445290
[TBL] [Abstract][Full Text] [Related]
20. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
